Study finds people with Crohn’s disease or ulcerative colitis face highest risk during flare-ups
Read the original here:
Inflammatory bowel disease hikes blood clots (Science News)
An early stage clinical trial of the experimental drug dimebon (latrepirdine) in people with Huntington’s disease appears to be safe and may improve cognition.
See more here:
Drug Shows Promise for Huntington's Disease | Edmund's Page
8 (Bloomberg) — A 27-year-old hay fever treatment being studied by Pfizer Inc. and Medivation Inc. for Alzheimer’s disease may also help patients with Huntington’s disease .
More here:
Pfizer, Medivation Drug May Help Huntington's Disease Patients
A study being published Monday offers hope for those with Huntington’s disease. The Archives of Neurology has a report about a drug aimed at the serious cognitive deficits that people with Huntington’s also suffer.
Read the original post:
New Data Point To Huntington’s Disease Hope (NPR)
( University of Rochester Medical Center ) An early stage clinical trial of the experimental drug dimebon (latrepirdine) in people with Huntington’s disease appears to be safe and may improve cognition. That is the conclusion of a study published today in the Archives of Neurology.
Original post:
Drug shows promise for Huntington’s disease (EurekAlert!)